UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Fibrocell Science, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware | 87-0458888 | |
(State of Incorporation or Organization) |
(I.R.S. Employer Identification No.) |
405 Eagleview Boulevard Exton, Pennsylvania |
19341 | |
(Address of Principal Executive Offices) | (Zip Code) |
Title of each class to be so registered |
Name of each exchange on which each class is to be registered | |
Common Stock, par value $0.001 per share | NYSE MKT LLC |
If this form relates to the registration of a securities pursuant to Section 12(b) of the Exchange Act and is effective upon filing pursuant to General Instruction A.(c), please check the following box. x
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. ¨
Securities Act registration statement file number to which this form relates: | ||||
(If applicable) |
Securities to be registered pursuant to Section 12(g) of the Act: None
Item 1. | Description of Registrants Securities to be Registered. |
Fibrocell Science, Inc. (the Registrant) hereby incorporates by reference the description of its common stock, par value $0.001 per share (the Common Stock), to be registered hereunder contained under the heading Description of Securities in the Registrants Registration Statement on Form S-3 (File No. 333-185466), as originally filed with the Securities and Exchange Commission (the Commission) on January 11, 2013 (the Registration Statement) and declared effective by the Commission on January 22, 2013. Any form of prospectus to the Registration Statement that includes such description and that is subsequently filed is also incorporated by reference herein.
Item 2. | Exhibits. |
The Common Stock to be registered on this Form 8-A is to be listed on the NYSE MKT LLC. In accordance with the instructions to Form 8-A, no exhibits are required to be filed as part of this Form 8-A because no other securities of the Registrant are registered on the NYSE MKT LLC and because the securities being registered on this Form 8-A are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
Dated: May 14, 2013
Fibrocell Science, Inc. | ||
By: | /s/ David Pernock | |
David Pernock, Chief Executive Officer |